Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Obese mice provide clues to a natural system that puts brakes on obesity

16.07.2003


First gene discovered that is switched on only in fat cells of obese mice

A gene that gets switched on only in the fat cells of obese mice may be a key to preventing obesity in humans, according to new research at The Rockefeller University in New York City and the Joslin Diabetes Center in Boston.

The finding, reported in the August 1 issue of the Journal of Clinical Investigation, marks the first time a gene has been identified that is induced, or activated, in the fat cells of obese animals. According to Rockefeller University professor Markus Stoffel, M.D., Ph.D., lead investigator of the study, the gene, called Foxa-2, inhibits young body cells from becoming mature fat-producing cells called adipocytes. In addition, when this gene is switched on in mature adipocytes, it functions as a brake to slow down further fat production and storage.



"We know a lot about the various molecular pathways that stimulate or promote fat production, and the focus has been on trying to block these pathways to fight obesity," says Stoffel. "This pathway is one of only a few that we know of that naturally work to counteract obesity.

"We have shown that Foxa-2 has two beneficial effects in mice: it counterregulates the formation of fat and it increases the activity of genes important for insulin sensitivity," Stoffel continues. "This is the ideal combination for pharmacologically treating obese or type 2 diabetic patients, or people with a risk of developing obesity."

Foxa-2 was originally discovered in the 1980s by Rockefeller scientist James E. Darnell Jr., M.D., as an activator of genes in the liver. Subsequent research by Stoffel and colleagues at Rockefeller showed that Foxa-2 also activates genes in the insulin-producing islet cells in the pancreas and it is expressed in the gut and the lung. However, previous research by scientists could not provide evidence for its expression in fat cells. The reason, says Stoffel, is "that we did not look at fat cells from obese animals."

"We were only able to find Foxa-2 in fat tissues when we extracted fat from a leptin-deficient mouse, which has a mutation in the ’ob’ gene," says Stoffel, referring to studies with mice that are obese due to low levels of the hormone leptin, the protein product of the obese gene, which was identified by Rockefeller professor Jeffrey M. Friedman, M.D., Ph.D., in the mid-1990s.

Leptin is a hormone secreted by adipocytes that acts on an area of the brain called the hypothalamus. Leptin, Stoffel notes, causes mice and people to lose weight by increasing food intake and energy expenditure, while Foxa-2’s effects are solely on the adipocyte at the level of the cell.

"The discovery of Foxa-2 in fat cells of obese mice was unexpected," Stoffel continues. "We were able to replicate this finding in mice that were obese due to mutations in several genes and in diet-induced obese mice."

Stoffel and colleagues found Foxa-2 expression in mature adipocytes and in pre-adipocytes, young cells that have not accumulated lipids. In addition, Foxa-2 expression was higher in visceral fat than in subcutaneous fat, which is stored under the skin. Visceral fat, found around the gut, is a form of fat that predisposes people to complications of obesity, including type 2 diabetes.

To understand Foxa-2’s role in pre-adipocytes, the Stoffel and his colleagues "overexpressed," or activated above normal levels, Foxa-2 in laboratory cultures of these cells. The scientists then added the necessary hormonal and nutritional signals for these cells to turn into mature fat cells. They found that the pre-adipocytes did not accumulate lipids, and Foxa-2 did not induce genes in these cells that typically are active in mature adipocytes.

During the normal course of differentiation of pre-adipocytes into fat, the activity or expression of a gene called Pref-1 decreases. Stoffel found that Foxa-2 activates Pref-1, and that this activation inhibited the transformation of the laboratory cultured pre-adipocytes into mature adipocytes. The researchers also found overexpression of a set of genes that metabolize glucose, suggesting that Foxa-2 also directly activates these genes.

When Foxa-2 was overexpressed in mature adipocytes that normally do not express Foxa-2, Stoffel and his colleagues found increased expression of genes that break down glucose and burn fat.

"We know that adipocytes of obese animal models are insulin-resistant, so levels of glucose metabolism enzymes decrease," says Stoffel. "At the level of the mature adipocyte, Foxa-2 seems to counterregulate obesity by increasing these enzymes in the adipocyte or at least working against further decreases."

The researchers then tested the effects of removing this gene in living mice. Because both copies of Foxa-2 are necessary for survival, the researchers deleted, or "knocked out," only one copy of this gene, which effectively reduced its activity by 50 percent. When fed a high fat diet for six weeks, these knockout mice gained much more weight than genetically normal mice fed the same diet.

Analysis of fat cells from the Foxa-2 knockout mice showed that activity levels of Pref-1 and the glucose metabolism genes decreased.
"It is now apparent that when we overfeed a mouse and it becomes obese, Foxa-2 is induced, which then activates a set of genes that work against obesity," says Stoffel. "Obviously that’s not sufficient to prevent obesity, but it is sufficient to slow it down. Without this force, the mice accumulate more fat.

"It’s an ineffective system, since otherwise people wouldn’t get obese, but it is clear that if you take the system away, there is an increase in obesity."

The next step for the researchers is to identify stimuli that induce Foxa-2 in people.

"We know that Foxa-2 is expressed in human adipocytes, and if we knew the stimuli that are responsible for inducing Foxa-2 we could potentially induce Foxa-2 activity in people at risk for developing obesity and possibly counteract the development of obesity as well as increase insulin sensitivity," says Stoffel. Both obesity and insulin resistance are risk factors for type 2 diabetes.

In their research with mice, Stoffel and his colleagues showed that growth hormone can induce Foxa-2 in cultured cells that normally don’t express the gene.

Stoffel cautions that growth hormone is not the answer for treating obesity in people.

"We do not believe that growth hormone is responsible for the induction of Foxa-2 in obesity because we know that obese patients actually have a relative deficiency of growth hormone," Stoffel says. "And, we can’t give growth hormone to patients because there are too many negative side effects."

Joseph Bonner | EurekAlert!
Further information:
http://www.rockefeller.edu

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>